GAD2 and type 1 diabetes mellitus: An evaluation of anti-CN1A analysis to the broader range of known anti-GAD65 autoantibody-associated autoimmune diseases (e.g. vitiligo, T1DM, Hashimoto’s thyroiditis) may also be considered [28, 29].